Citations

Clear

31 citation(s) found for "Alexander, Gene".

P‐020: Regional gray matter reductions in Alzheimer's dementia and amnestic mild cognitive impairment: Preliminary findings from the Alzheimer's disease neuroimaging initiative using voxel‐based morphometry
Alexander, Gene E. , Reiman, Eric M. , Aschenbrenner, Melaney, Hanson, Krista D., Kornak, John , Schuff, Norbert, Weiner, Michael W. , Chen, Kewei , Merkley, Tricia L. , Dale, Anders M. , Bernstein, Matt A. , Fox, Nick C. , Thompson, Paul M. , Jack, Clifford R.

Mayo Clinic

Alzheimer's & Dementia | June 4, 2007 | Volume: 3 | Issue: 3S_Part_1 | Pages: No page available

10.1016/j.jalz.2007.04.236 Get It

O1–05–03: PET measurements of posterior cingulate glucose metabolism are superior to MRI measurements of hippocampal volume in distinguishing cognitively normal persons at differential genetic risk for Alzheimer's disease
Reiman, Eric M. , Alexander, Gene E. , Reschke, Cole, Lee, Wendy , Smilovici, Oded, Buckley, Shannon, Sacrey, Diana Truran, Schuff, Norbert, Müller, Stig , Weiner, Michael W. , Caselli, Richard J., Chen, Kewei , Smilovici, Oded

Mayo Clinic

Alzheimer's & Dementia | June 4, 2007 | Volume: 3 | Issue: 3S_Part_3 | Pages: No page available

10.1016/j.jalz.2007.04.070 Get It

Gene expression profiles in anatomically and functionally distinct regions of the normal aged human brain
Liang, Winnie S. , Dunckley, Travis , Beach, Thomas G. , Grover, Andrew, Mastroeni, Diego , Walker, Douglas G. , Caselli, Richard J. , Kukull, Walter A. , McKeel, Daniel W., Morris, John C. , Hulette, Christine, Schmechel, Donald E., Alexander, Gene E. , Reiman, Eric M. , Rogers, Joseph, Stephan, Dietrich A. , Morris, John C

Mayo Clinic

Physiological Genomics | October 31, 2006 | Volume: 28 | Issue: 3 | Pages: 311-322

10.1152/physiolgenomics.00208.2006 | PMID 17077275 Get It

In this article, we have characterized and compared gene expression profiles from laser capture microdissected neurons in six functionally and anatomically distinct regions from clinically and histopathologically normal aged human brains. These regions, which are also known to be differentially vulnerable to the histopathological and metabolic features of Alzheimer’s disease (AD), include the entorhinal cortex and hippocampus (limbic and paralimbic areas vulnerable to early neurofibrillary tangle pathology in AD), posterior cingulate cortex (a paralimbic area vulnerable to early metabolic abnormalities in AD), temporal and prefrontal cortex (unimodal and heteromodal sensory association areas vulnerable to early neuritic plaque pathology in AD), and primary visual cortex (a primary sensory area relatively spared in early AD). These neuronal profiles will provide valuable reference information for future studies of the brain, in normal aging, AD and other neurological and psychiatric disorders.
IC–P–045: Using partial–least squares to demonstrate a correlation between combined PET/MRI scores and apolipoprotein E ϵ4 gene dose
Reiman, Eric M. , Alexander, Gene E. , Caselli, Richard J., Bandy, Dan, Chen, Kewei

Mayo Clinic

Alzheimer's & Dementia | August 17, 2006 | Volume: 2 | Issue: 3S_Part_22 | Pages: No page available

10.1016/j.jalz.2006.05.2250 Get It

IC–P–025: Regional network pattern of MRI gray matter volume in Alzheimer's dementia
Alexander, Gene E. , Aschenbrenner, Melaney, Reiman, Eric M. , Caselli, Richard J., Rapoport, Stanley I., Moeller, James R., Chen, Kewei , Merkley, Tricia L. , Lewis, Diana J. , Pietrini, Pietro , Teipel, Stefan Johannes , Hampel, Harald

Mayo Clinic

Alzheimer's & Dementia | August 17, 2006 | Volume: 2 | Issue: 3S_Part_21 | Pages: No page available

10.1016/j.jalz.2006.05.2230 Get It

P2–194: Presymptomatic longitudinal decline in frontally mediated cognitive skills and memory in cognitively normal late middle aged APOE e4 carriers
Caselli, Richard J. , Hentz, Joseph G. , Osborne, David, Hoffman‐Snyder, Charlene , Alexander, Gene E. , Reiman, Eric M.

Mayo Clinic

Alzheimer's & Dementia | August 17, 2006 | Volume: 2 | Issue: 3S_Part_10 | Pages: No page available

10.1016/j.jalz.2006.05.1032 Get It

[O1‐01‐06]: Correlations between cholesterol‐related genetic risk scores and lower brain‐imaging measurements of regional glucose metabolism
Reiman, Eric M. , Caselli, Richard J. , Bandy, Daniel, Alexander, Gene E. , Stephan, Dietrich A. , Chen, Kewei , Lee, Wendy , Papassotiropoulos, Andreas

Mayo Clinic

Alzheimer's & Dementia | August 25, 2005 | Volume: 1 | Issue: 1S_Part_3 | Pages: No page available

10.1016/j.jalz.2005.06.281 Get It

[P‐121]: Resting FDG‐PET in neurologically normal individuals reporting dream enactment behavior: Preclinical dementia with lewy bodies?
Caselli, Richard J. , Reiman, Eric M. , Alexander, Gene E. , Osborne, David, Parish, James M., Krahn, Lois E., Chen, Kewei , Boeve, Bradley F.

Mayo Clinic

Alzheimer's & Dementia | August 25, 2005 | Volume: 1 | Issue: 1S_Part_2 | Pages: No page available

10.1016/j.jalz.2005.06.194 Get It

Correlations between apolipoprotein E ε4 gene dose and brain-imaging measurements of regional hypometabolism
Reiman, Eric M. , Chen, Kewei , Alexander, Gene E. , Caselli, Richard J. , Bandy, Daniel, Osborne, David, Saunders, Ann M. , Hardy, John , Hardy, John

Mayo Clinic

Proceedings of the National Academy of Sciences | June 2, 2005 | Volume: 102 | Issue: 23 | Pages: 8299-8302

10.1073/pnas.0500579102 | PMID 15932949 Get It

Patients with Alzheimer's disease (AD) have abnormally low positron emission tomography (PET) measurements of the cerebral metabolic rate for glucose (CMRgl) in regions of the precuneus and the posterior cingulate, parietotemporal, and frontal cortex. Apolipoprotein E (APOE) ε4 gene dose (i.e., the number of ε4 alleles in a person's APOE genotype) is associated with a higher risk of AD and a younger age at dementia onset. We previously found that cognitively normal late-middle-aged APOE ε4 carriers have abnormally low CMRgl in the same brain regions as patients with probable Alzheimer's dementia. In a PET study of 160 cognitively normal subjects 47–68 years of age, including 36 ε4 homozygotes, 46 heterozygotes, and 78 ε4 noncarriers who were individually matched for their gender, age, and educational level, we now find that ε4 gene dose is correlated with lower CMRgl in each of these brain regions. This study raises the possibility of using PET as a quantitative presymptomatic endophenotype to help evaluate the individual and aggregate effects of putative genetic and nongenetic modifiers of AD risk.
Functional brain abnormalities in young adults at genetic risk for late-onset Alzheimer's dementia
Reiman, Eric M. , Chen, Kewei , Alexander, Gene E. , Caselli, Richard J. , Bandy, Daniel, Osborne, David, Saunders, Ann M. , Hardy, John , Hardy, John

Mayo Clinic

Proceedings of the National Academy of Sciences | January 6, 2004 | Volume: 101 | Issue: 1 | Pages: 284-289

10.1073/pnas.2635903100 | PMID 14688411 Get It

Fluorodeoxyglucose positron emission tomography (PET) studies have found that patients with Alzheimer's dementia (AD) have abnormally low rates of cerebral glucose metabolism in posterior cingulate, parietal, temporal, and prefrontal cortex. We previously found that cognitively normal, late-middle-aged carriers of the apolipoprotein E ε4 allele, a common susceptibility gene for late-onset Alzheimer's dementia, have abnormally low rates of glucose metabolism in the same brain regions as patients with probable AD. We now consider whether ε4 carriers have these regional brain abnormalities as relatively young adults. Apolipoprotein E genotypes were established in normal volunteers 20–39 years of age. Clinical ratings, neuropsychological tests, magnetic resonance imaging, and PET were performed in 12 ε4 heterozygotes, all with the ε3/ε4 genotype, and 15 noncarriers of the ε4 allele, 12 of whom were individually matched for sex, age, and educational level. An automated algorithm was used to generate an aggregate surface-projection map that compared regional PET measurements in the two groups. The young adult ε4 carriers and noncarriers did not differ significantly in their sex, age, educational level, clinical ratings, or neuropsychological test scores. Like previously studied patients with probable AD and late-middle-aged ε4 carriers, the young ε4 carriers had abnormally low rates of glucose metabolism bilaterally in the posterior cingulate, parietal, temporal, and prefrontal cortex. Carriers of a common Alzheimer's susceptibility gene have functional brain abnormalities in young adulthood, several decades before the possible onset of dementia.